Remission of recalcitrant dermatomyositis treated with ruxolitinib

N Engl J Med. 2014 Dec 25;371(26):2537-8. doi: 10.1056/NEJMc1412997.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use*
  • Dermatomyositis / drug therapy*
  • Female
  • Humans
  • Janus Kinase 2 / genetics
  • Janus Kinases / antagonists & inhibitors*
  • Nitriles
  • Polycythemia Vera / drug therapy
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Anti-Inflammatory Agents
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • JAK2 protein, human
  • Janus Kinase 2
  • Janus Kinases